BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21709147)

  • 1. Special article: Future directions in malignant hyperthermia research and patient care.
    Hirshey Dirksen SJ; Larach MG; Rosenberg H; Brandom BW; Parness J; Lang RS; Gangadharan M; Pezalski T
    Anesth Analg; 2011 Nov; 113(5):1108-19. PubMed ID: 21709147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference.
    Riazi S; Kraeva N; Muldoon SM; Dowling J; Ho C; Petre MA; Parness J; Dirksen RT; Rosenberg H
    Can J Anaesth; 2014 Nov; 61(11):1040-9. PubMed ID: 25189431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anesthetic malignant hyperthermia: what's new in 2012?].
    Nivoche Y; Bruneau B; Dahmani S
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):e43-7. PubMed ID: 23290613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant hyperthermia. The ugly].
    Rüffert H; Wehner M; Deutrich C; Olthoff D
    Anaesthesist; 2007 Sep; 56(9):923-9. PubMed ID: 17565473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: exertional heat stroke-induced myopathy and genetically inherited malignant hyperthermia represent the same disorder, the human stress syndrome.
    Zhao X; Song Q; Gao Y
    Cell Biochem Biophys; 2014 Nov; 70(2):1325-9. PubMed ID: 24948473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant hyperthermia].
    Urwyler A; Hartung E
    Anaesthesist; 1994 Aug; 43(8):557-69. PubMed ID: 7978181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C
    PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].
    Grander W
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):407-16. PubMed ID: 27272514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the nature of the link between malignant hyperthermia and exertional heatstroke.
    Bourdon L; Canini F
    Med Hypotheses; 1995 Sep; 45(3):268-70. PubMed ID: 8569550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test.
    Roux-Buisson N; Monnier N; Sagui E; Abriat A; Brosset C; Bendahan D; Kozak-Ribbens G; Gazzola S; Quesada JL; Foutrier-Morello C; Rendu J; Figarella-Branger D; Cozonne P; Aubert M; Bourdon L; Lunardi J; Fauré J
    Br J Anaesth; 2016 Apr; 116(4):566-8. PubMed ID: 26994242
    [No Abstract]   [Full Text] [Related]  

  • 13. Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.
    Hosokawa Y; Casa DJ; Rosenberg H; Capacchione JF; Sagui E; Riazi S; Belval LN; Deuster PA; Jardine JF; Kavouras SA; Lee EC; Miller KC; Muldoon SM; O'Connor FG; Sailor SR; Sambuughin N; Stearns RL; Adams WM; Huggins RA; Vandermark LW
    J Athl Train; 2017 Apr; 52(4):377-383. PubMed ID: 28430550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Halliday NJ
    J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia: fatigue characteristics of skeletal muscle.
    Balog EM; Enzmann NR; Gallant EM
    Muscle Nerve; 2000 Feb; 23(2):223-30. PubMed ID: 10639615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Hyperthermia.
    Kaur H; Katyal N; Yelam A; Kumar K; Srivastava H; Govindarajan R
    Mo Med; 2019; 116(2):154-159. PubMed ID: 31040503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex].
    Lunardi J; Monnier N
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S70-7. PubMed ID: 15269663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment.
    McCarthy EJ
    AACN Clin Issues; 2004; 15(2):231-7. PubMed ID: 15461040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia, a Scandinavian update.
    Broman M; Islander G; Müller CR
    Acta Anaesthesiol Scand; 2015 Sep; 59(8):951-61. PubMed ID: 25989378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.